O6-methylguanine DNA methyltransferase (MGMT) gene promoter methylation and IDH mutation status allow for the stratification into biologically and prognostically distinct subgroups of glioma patients, PsP being more frequent [48]. Here, MGMT is linked to central nervous system cancer.